Latest filing published 15 Apr 2026 for Myriad Genetics INC, €4,448. Read the official filing
All filings by Mark Verratti on record concern Myriad Genetics Inc. Over a trading history stretching from 25 August 2021 to 14 April 2026, the count stands at 33 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 15 April 2026 came the latest disclosure, a share grant for €4,448 in Myriad Genetics Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations